TScan Therapeutics, Inc. (TCRX)
1.25
+0.04
(+3.31%)
USD |
NASDAQ |
May 06, 16:00
1.29
+0.04
(+3.20%)
After-Hours: 20:00
TScan Therapeutics EPS Diluted (Quarterly) : -0.1769 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lexicon Pharmaceuticals, Inc. | -0.0427 |
| Agios Pharmaceuticals, Inc. | -1.686 |
| Sutro Biopharma, Inc. | -5.447 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.98M |
| Revenue (Quarterly) | 2.567M |
| Total Expenses (Quarterly) | 25.54M |
| Enterprise Value | 14.45M |
| Gross Profit Margin (Quarterly) | 71.83% |
| Profit Margin (Quarterly) | -895.1% |
| Earnings Yield | -79.99% |
| Normalized Earnings Yield | -80.00 |